-
-
-
-
-
-
-
BioStem Technologies files restated financial statements
-
-
-
-
-
-
-
BioStem Technologies Provides Comments on CMS CY 2026 Proposed Medicare Reimbursement Rule Changes for Skin Substitutes
-
-
-
-
-
-
-
BioStem Technologies to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on April 14, 2025
-
-
-
-
-
-
-
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
-
-
-
-
-
-
-
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
-
-
-
-
-
-
-
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
-
-
-
-
-
-
-
BioStem Technologies Announces Filing of 2021 First Quarter Financial Reports
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

